Developer docs
API playgroundTry for free, no card

Search company profiles

AerBetic

Full company profile

uuid0005fyj

Namestring
AerBetic
Legal namestring
AerBetic, Inc.
Websiteurl
aerbetic.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

AerBetic, Inc. is a Birmingham, Alabama-based, founder-led startup founded in 2018 by Arnar Thors that is developing a non-invasive, wearable diabetes alert system designed to detect hypoglycemic and hyperglycemic episodes without finger sticks or subcutaneous sensors. The core product consists of a wearable device (bracelet or pendant form factor) that integrates MEMS-based nano gas sensors — sourced through a core partnership with AerNos — to analyze volatile organic compounds in exhaled breath at parts-per-billion concentrations, paired with a companion iOS mobile app that displays status, pushes alerts, and enables 24/7 caregiver monitoring. The product also runs a continuous-learning personalization loop in which patients input actual glucose readings so the system can refine its detection to each user's unique breath signature over time.

The company monetizes through hardware sales of the wearable device and a presumed subscription/freemium model around the mobile app, with pricing positioned below incumbent continuous glucose monitoring solutions; a 6–8 month beta tester program with lifetime discounts serves as the conversion mechanism. Distribution is direct-to-consumer via its own website, with no app store listing captured and Android explicitly deferred. The customer base is split between Type 1 diabetic patients (primary segment) and their caregivers — especially parents of diabetic children — with no enterprise or institutional contracts disclosed.

AerBetic is pre-commercial as of the most recent available evidence: the website labels the product "Coming Soon," headcount sits at 1–10, on-record capital consists of a 2019 ~$100K raise and the Southern Research i6 Challenge Grant plus the Alabama LaunchPad prize. Its go-to-market has leaned heavily on earned media (Wired, CNBC, Fox, CBS, ABC, Chicago Tribune, Smithsonian Magazine), CES exhibitions (CES 2019 and CES 2020 Innovation Award Honoree in Health and Wellness), and social/community channels rather than paid acquisition or institutional sales.

Short descriptiontext

AerBetic is a Birmingham, Alabama-based startup developing a non-invasive wearable bracelet/pendant that uses MEMS-based nano gas sensors to detect volatile organic compounds in exhaled breath, alerting Type 1 diabetic patients and their caregivers to hypoglycemic and hyperglycemic episodes via a companion iOS app.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBirmingham, United States
HQ citystring
Birmingham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
non-invasive glucose monitoring, diabetes alert wearables, breath-based diagnostics, continuous glucose monitoring, medical wearables
Industry2 codes
PRIMARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Other Measuring and Controlling Device Manufacturing334519
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
Non-invasive Diabetes Monitoring Wearables
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Wearable Device Sales
TypeHardware Sales
Description

Sale of wearable hardware devices (bracelets and pendants) containing the nano-gas sensor technology. The company mentions the system will cost less than most glucose monitoring solutions.

aerbetic.com
2Mobile App Services
TypeSubscription Recurring
Description

Companion smartphone app (iOS only at launch) that displays current and recent data, provides alerts, and enables caregiver monitoring. Likely operates on subscription or freemium model with premium features.

aerbetic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Wearable device with app - Coming Soon
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed. The company states it will be affordable and cost less than most glucose monitoring solutions. Beta testers receive lifetime discounts.

aerbetic.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

AerBetic develops and sells non-invasive wearable diabetes alert devices that use proprietary MEMS-based nano-gas sensors to detect volatile organic compound (VOC) signatures associated with hyperglycemia and hypoglycemia in a user's exhaled breath. The hardware is paired with a companion mobile application that delivers alerts, tracks readings, and connects users to caregivers, providing an alternative to finger-stick blood glucose monitoring.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Non-invasive glucose monitoring eliminates need for finger sticks and continuous blood glucose monitoring devices
+1 more record
Product overview1 text field

AerBetic offers a non-invasive wearable diabetes monitoring system consisting of two main components: (1) the AerBetic Wearable Device, available as a bracelet or pendant, which uses nano-gas sensors to detect volatile organic compounds in exhaled breath indicative of hypoglycemic and hyperglycemic episodes, and (2) the AerBetic Mobile App (iOS), which receives alerts from the device, displays status data, and enables caregivers to monitor patients 24/7. The system employs machine learning to personalize detection to each user's unique breath signature over time.

Product and service2 records
1AerBetic Wearable Device
CategoryMedical Wearables / Diabetes Monitoring Devices
2AerBetic Mobile App
CategoryHealth Monitoring Software
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1AerNos
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-11-11
Description

AerNos (San Diego-based company) provides MEMS-based nano gas sensors used in AerBetic devices. The sensors analyze exhaled breath to detect potentially dangerous blood glucose levels. AerBetic exhibited in the AerNos booth at CES events. This is a critical technology partnership for the core sensor functionality.

aerbetic.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-02-01
Description

Kristen Noles, a Nurse Leader at UAB, provided endorsement and clinical perspective on AerBetic's technology. She noted that Type 1 Diabetics and caregivers have been seeking non-invasive monitoring solutions. Her clinical endorsement validates the product's potential impact.

Strategic tierMinorTypeOthersAnnounced on2018-07-01
Description

Southern Research awarded AerBetic a research grant (i6 Challenge Grant) to support development of the non-invasive diabetes monitoring technology. This is a grant/funding relationship rather than a commercial partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Market leader in continuous glucose monitoring (CGM) hardware (G6, G7). Most directly comparable competitor as both companies offer wearable glucose-monitoring devices for diabetic patients, with Dexcom's invasive subcutaneous sensor setting the accuracy bar AerBetic's non-invasive approach must clear.

TypeDirect peer
Description

Public company developing a non-invasive glucose monitor (UBand) using radiofrequency spectroscopy in a wrist-worn form factor. Closely comparable as a non-invasive, wearable consumer glucose monitor competing for the same end users.

TypeDirect peer
Description

Offers the Guardian Connect CGM and integrated insulin pump systems. Comparable as an incumbent in wearable diabetes monitoring with deep clinical and payer relationships that any new entrant must navigate.

TypeDirect peer
Description

Sells the FreeStyle Libre family of CGM sensors, the highest-volume CGM platform globally. Directly comparable as a wearable glucose monitor for diabetic patients, with an installed-base and cost advantage AerBetic will need to undercut or differentiate against.

TypeEmerging player
Description

Berlin-based developer of non-invasive glucose monitoring using infrared spectroscopy. Comparable as a non-invasive glucose technology developer, though its form factor (desktop/handheld) differs from AerBetic's wearable.

TypeBroad incumbent
Description

Major incumbent in blood glucose monitoring (Accu-Chek) with deep pharmacy and payer distribution. Comparable as a broad glucose-monitoring incumbent that AerBetic would need to displace in retail channels.

TypeDirect peer
Description

Startup developing a non-invasive, wrist-worn continuous glucose monitor using dielectric spectroscopy. Comparable in approach (non-invasive wearable) and in targeting the same Type 1 / Type 2 diabetic consumer segment.

TypeEmerging player
Description

Developer of a non-invasive, multi-parameter wearable health monitor (including glucose trending) using spectroscopy. Comparable as an emerging non-invasive wearable health device company targeting similar chronic-disease consumers.

TypeDirect peer
Description

Developer of sugarBEAT, a non-invasive, wearable adhesive CGM patch using skin-patch sensors. The most directly comparable company in approach (non-invasive, wearable) and stage (pre-commercial / early commercial) to AerBetic.

TypeDirect peer
Description

Maker of Eversense, an implantable long-term CGM (up to 180 days). Comparable as a glucose-monitoring company pursuing an alternative form factor to incumbent finger-stick and short-term CGM approaches.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AerBetic

Non-invasive Diabetes Monitoring Wearablesaerbetic.com

AerBetic is a Birmingham, Alabama-based startup developing a non-invasive wearable bracelet/pendant that uses MEMS-based nano gas sensors to detect volatile organic compounds in exhaled breath, alerting Type 1 diabetic patients and their caregivers to hypoglycemic and hyperglycemic episodes via a companion iOS app.

What AerBetic does

AerBetic, Inc. is a Birmingham, Alabama-based, founder-led startup founded in 2018 by Arnar Thors that is developing a non-invasive, wearable diabetes alert system designed to detect hypoglycemic and hyperglycemic episodes without finger sticks or subcutaneous sensors. The core product consists of a wearable device (bracelet or pendant form factor) that integrates MEMS-based nano gas sensors — sourced through a core partnership with AerNos — to analyze volatile organic compounds in exhaled breath at parts-per-billion concentrations, paired with a companion iOS mobile app that displays status, pushes alerts, and enables 24/7 caregiver monitoring. The product also runs a continuous-learning personalization loop in which patients input actual glucose readings so the system can refine its detection to each user's unique breath signature over time.

The company monetizes through hardware sales of the wearable device and a presumed subscription/freemium model around the mobile app, with pricing positioned below incumbent continuous glucose monitoring solutions; a 6–8 month beta tester program with lifetime discounts serves as the conversion mechanism. Distribution is direct-to-consumer via its own website, with no app store listing captured and Android explicitly deferred. The customer base is split between Type 1 diabetic patients (primary segment) and their caregivers — especially parents of diabetic children — with no enterprise or institutional contracts disclosed.

AerBetic is pre-commercial as of the most recent available evidence: the website labels the product "Coming Soon," headcount sits at 1–10, on-record capital consists of a 2019 ~$100K raise and the Southern Research i6 Challenge Grant plus the Alabama LaunchPad prize. Its go-to-market has leaned heavily on earned media (Wired, CNBC, Fox, CBS, ABC, Chicago Tribune, Smithsonian Magazine), CES exhibitions (CES 2019 and CES 2020 Innovation Award Honoree in Health and Wellness), and social/community channels rather than paid acquisition or institutional sales.

AerBetic firmographics

Firmographics
Name
AerBetic
Legal name
AerBetic, Inc.
Website
https://aerbetic.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
AerBetic is a Birmingham, Alabama-based startup developing a non-invasive wearable bracelet/pendant that uses MEMS-based nano gas sensors to detect volatile organic compounds in exhaled breath, alerting Type 1 diabetic patients and their caregivers to hypoglycemic and hyperglycemic episodes via a companion iOS app.
Ownership category
akta.pro rank

AerBetic industry classification

Industry
Product category
Non-invasive Diabetes Monitoring Wearables
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYCRACAQAE
Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
SECONDARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

Keywords

  • Non-invasive glucose monitoring
  • Diabetes alert wearables
  • Breath-based diagnostics
  • Continuous glucose monitoring
  • Medical wearables

Where AerBetic is headquartered

Location

Headquarters

HQ city
Birmingham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AerBetic business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Wearable Device Sales: Sale of wearable hardware devices (bracelets and pendants) containing the nano-gas sensor technology. The company mentions the system will cost less than most glucose monitoring solutions.
  2. Mobile App Services: Companion smartphone app (iOS only at launch) that displays current and recent data, provides alerts, and enables caregiver monitoring. Likely operates on subscription or freemium model with premium features.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goWearable device with app - Coming Soon

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

AerBetic product offering

Product offering

Core offering

AerBetic develops and sells non-invasive wearable diabetes alert devices that use proprietary MEMS-based nano-gas sensors to detect volatile organic compound (VOC) signatures associated with hyperglycemia and hypoglycemia in a user's exhaled breath. The hardware is paired with a companion mobile application that delivers alerts, tracks readings, and connects users to caregivers, providing an alternative to finger-stick blood glucose monitoring.

Product overview

AerBetic offers a non-invasive wearable diabetes monitoring system consisting of two main components: (1) the AerBetic Wearable Device, available as a bracelet or pendant, which uses nano-gas sensors to detect volatile organic compounds in exhaled breath indicative of hypoglycemic and hyperglycemic episodes, and (2) the AerBetic Mobile App (iOS), which receives alerts from the device, displays status data, and enables caregivers to monitor patients 24/7. The system employs machine learning to personalize detection to each user's unique breath signature over time.

Differentiator

Problem solved

Functional benefit

Products and services

  • AerBetic Wearable Device
  • AerBetic Mobile App

Quantifiable outcome

  • Non-invasive glucose monitoring eliminates need for finger sticks and continuous blood glucose monitoring devices
  • +1 more outcomes

Companies that use AerBetic

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

AerBetic technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

AerBetic partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • AerNoscoreTechnology or Integration · 11 November 2019AerNos (San Diego-based company) provides MEMS-based nano gas sensors used in AerBetic devices. The sensors analyze exhaled breath to detect potentially dangerous blood glucose levels. AerBetic exhibited in the AerNos booth at CES events. This is a critical technology partnership for the core sensor functionality.
  • University of Alabama at Birmingham (Kristen Noles, DNP, RN, CNL)minorStrategic or Co-development Partner · 1 February 2019Kristen Noles, a Nurse Leader at UAB, provided endorsement and clinical perspective on AerBetic's technology. She noted that Type 1 Diabetics and caregivers have been seeking non-invasive monitoring solutions. Her clinical endorsement validates the product's potential impact.
  • Southern ResearchminorOthers · 1 July 2018Southern Research awarded AerBetic a research grant (i6 Challenge Grant) to support development of the non-invasive diabetes monitoring technology. This is a grant/funding relationship rather than a commercial partnership.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

AerBetic competitors and assessment

Company assessment

Direct peers

  • Dexcom: Market leader in continuous glucose monitoring (CGM) hardware (G6, G7). Most directly comparable competitor as both companies offer wearable glucose-monitoring devices for diabetic patients, with Dexcom's invasive subcutaneous sensor setting the accuracy bar AerBetic's non-invasive approach must clear.
  • Know Labs: Public company developing a non-invasive glucose monitor (UBand) using radiofrequency spectroscopy in a wrist-worn form factor. Closely comparable as a non-invasive, wearable consumer glucose monitor competing for the same end users.
  • Medtronic Diabetes: Offers the Guardian Connect CGM and integrated insulin pump systems. Comparable as an incumbent in wearable diabetes monitoring with deep clinical and payer relationships that any new entrant must navigate.
  • Abbott Diabetes Care (FreeStyle Libre): Sells the FreeStyle Libre family of CGM sensors, the highest-volume CGM platform globally. Directly comparable as a wearable glucose monitor for diabetic patients, with an installed-base and cost advantage AerBetic will need to undercut or differentiate against.
  • Alertgy: Startup developing a non-invasive, wrist-worn continuous glucose monitor using dielectric spectroscopy. Comparable in approach (non-invasive wearable) and in targeting the same Type 1 / Type 2 diabetic consumer segment.
  • Nemaura Medical: Developer of sugarBEAT, a non-invasive, wearable adhesive CGM patch using skin-patch sensors. The most directly comparable company in approach (non-invasive, wearable) and stage (pre-commercial / early commercial) to AerBetic.
  • Senseonics (Eversense): Maker of Eversense, an implantable long-term CGM (up to 180 days). Comparable as a glucose-monitoring company pursuing an alternative form factor to incumbent finger-stick and short-term CGM approaches.

Emerging players

  • DiaMonTech: Berlin-based developer of non-invasive glucose monitoring using infrared spectroscopy. Comparable as a non-invasive glucose technology developer, though its form factor (desktop/handheld) differs from AerBetic's wearable.
  • LifePlus: Developer of a non-invasive, multi-parameter wearable health monitor (including glucose trending) using spectroscopy. Comparable as an emerging non-invasive wearable health device company targeting similar chronic-disease consumers.

Broad incumbents

  • Roche Diabetes Care: Major incumbent in blood glucose monitoring (Accu-Chek) with deep pharmacy and payer distribution. Comparable as a broad glucose-monitoring incumbent that AerBetic would need to displace in retail channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

AerBetic social profiles

Digital presence

AerBetic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AerBetic leadership team

Management profile

Number of profiles

Profiles3 records

AerBetic funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AerBetic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AerBetic

What does AerBetic do?

AerBetic develops and sells non-invasive wearable diabetes alert devices that use proprietary MEMS-based nano-gas sensors to detect volatile organic compound (VOC) signatures associated with hyperglycemia and hypoglycemia in a user's exhaled breath. The hardware is paired with a companion mobile application that delivers alerts, tracks readings, and connects users to caregivers, providing an alternative to finger-stick blood glucose monitoring.

Is AerBetic a public or private company?

AerBetic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AerBetic founded?

AerBetic was founded in 2018. It employs 1 to 10 people.

Where is AerBetic based?

AerBetic is headquartered in Birmingham, United States, in the North America region.

How does AerBetic make money?

Two revenue lines are on record. Wearable Device Sales are the primary driver. The others are mobile App Services.

Who are AerBetic's main competitors?

Direct peers on record are Dexcom, Know Labs, Medtronic Diabetes, Abbott Diabetes Care (FreeStyle Libre), Alertgy, Nemaura Medical and Senseonics (Eversense). Emerging players are DiaMonTech and LifePlus. Roche Diabetes Care is listed as a broad incumbent.

Does AerBetic have an API?

No public API is recorded for AerBetic.

What industry is AerBetic in?

AerBetic's product category is Non-invasive Diabetes Monitoring Wearables. Its primary akta.pro industry code is CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers), with a secondary code of HLAHAHAG, Blood Glucose Monitoring (BGM) Meters & Test Strips. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals